Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 23;14(1):19.
doi: 10.3390/brainsci14010019.

Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?

Affiliations
Review

Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?

Carmela Rita Balistreri et al. Brain Sci. .

Abstract

The term "neuroinflammation" defines the typical inflammatory response of the brain closely related to the onset of many neurodegenerative diseases (NDs). Neuroinflammation is well known, but its mechanisms and pathways are not entirely comprehended. Some progresses have been achieved through many efforts and research. Consequently, new cellular and molecular mechanisms, diverse and conventional, are emerging. In listing some of those that will be the subject of our description and discussion, essential are the important roles of peripheral and infiltrated monocytes and clonotypic cells, alterations in the gut-brain axis, dysregulation of the apelinergic system, alterations in the endothelial glycocalyx of the endothelial component of neuronal vascular units, variations in expression of some genes and levels of the encoding molecules by the action of microRNAs (miRNAs), or other epigenetic factors and distinctive transcriptional factors, as well as the role of autophagy, ferroptosis, sex differences, and modifications in the circadian cycle. Such mechanisms can add significantly to understanding the complex etiological puzzle of neuroinflammation and ND. In addition, they could represent biomarkers and targets of ND, which is increasing in the elderly.

Keywords: emerging mechanisms; neurodegenerative diseases; neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(by Biorender software version 04): Important drivers, i.e., alterations in the MGB axis, infections, and ischemia contribute to the activation and infiltration of circulating monocytes in the brain and their specific secretion of inflammation mediators. These latter influence the activation of other resident immune cells, thus leading to neuroinflammation and neurodegeneration. Similarly, clonotype cells influence neuroinflammation.
Figure 2
Figure 2
(A,B) (by Biorender software): Model describing the novel mechanisms involved in neuroinflammation and its relation to the onset of ND. In (A), it illustrates how the ferroptosis, autophagy, epigenetic factors, changes in circadian rhythm, and endothelial dysfunction associated with cerebrovascular insufficiency determine all the activation of NF-kB pathway through canonical or non-canonical signaling. In (B), it shows how activation of the NF-kB pathway through canonical or non-canonical signaling can activate a network of different signaling pathways, all related to the onset of neuroinflammation and the consequent onset of ND.
Figure 2
Figure 2
(A,B) (by Biorender software): Model describing the novel mechanisms involved in neuroinflammation and its relation to the onset of ND. In (A), it illustrates how the ferroptosis, autophagy, epigenetic factors, changes in circadian rhythm, and endothelial dysfunction associated with cerebrovascular insufficiency determine all the activation of NF-kB pathway through canonical or non-canonical signaling. In (B), it shows how activation of the NF-kB pathway through canonical or non-canonical signaling can activate a network of different signaling pathways, all related to the onset of neuroinflammation and the consequent onset of ND.

References

    1. Disabato D.J., Quan N., Godbout J.P. Neuroinflammation: The devil is in the details. J. Neurochem. 2016;139((Suppl. 2)):136–153. doi: 10.1111/jnc.13607. - DOI - PMC - PubMed
    1. Gilhus N.E., Deuschl G. Neuroinflammation—A common thread in neurological disorders. Nat. Rev. Neurol. 2019;15:429–430. doi: 10.1038/s41582-019-0227-8. - DOI - PubMed
    1. Gao C., Jiang J., Tan Y., Chen S. Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets. Signal Transduct. Target. Ther. 2023;8:359. doi: 10.1038/s41392-023-01588-0. - DOI - PMC - PubMed
    1. Ní Chasaide C., Lynch M.A. The role of the immune system in driving neuroinflammation. Brain Neurosci. Adv. 2020;4:2398212819901082. doi: 10.1177/2398212819901082. - DOI - PMC - PubMed
    1. Becher B., Spath S., Goverman J. Cytokine networks in neuroinflammation. Nat. Rev. Immunol. 2017;17:49–59. doi: 10.1038/nri.2016.123. - DOI - PubMed

LinkOut - more resources